1. Home
  2. Nation
  3. Covid-19 Vaccination: Centre to bear expenses of 3 crore frontline workers in first-phase

Covid-19 Vaccination: Centre to bear expenses of 3 crore frontline workers in first-phase

By Saima Siddiqui 
Updated Date
Covid-19 Vaccination: Centre to bear expenses of 3 crore frontline workers in first-phase

New Delhi: In his ambitious drive to eradicate Corona Virus from India, Prime Minister Narendra Modi on Monday held a meeting with chief ministers of all states to discuss the COVID-19 situation and announced that the cost of Covid-19 vaccination in first phase, covering around 3 crore people, would be borne by the central government. He also stated that the Public representatives will not be part of this vaccination project comprising of 3-crore people but corona warriors and frontline workers would be first to get the vaccine.

Also Read :- DCGI approves Zydus Cadila’s anti-COVID-19 drug Virafin for emergency use

In his interaction he also discussed to roll-out that Covid-19 vaccination will be kicked off on January 16 across the country. It was reportedly PM’s first interaction with CMs following the recent approval of two coronavirus vaccines for restricted emergency use by India’s drug regulator. However, the prime minister has often held meetings with state chief ministers following the pandemic’s outbreak in the country.

Also Read: Corona virus recovery rate in India stands at 96.42%, claims Centre

To note, India’s drugs regulator has approved Oxford vaccine Covishield that is manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the nation.

Meanwhile, the two already approved made-in-India COVID-19 vaccines are touted to be more cost-effective than any other in the world and have been developed as per the country’s needs. In his interaction with the CMs of all states regarding COVID-19 situation and the vaccination drive, Modi also established that apart from the two already approved vaccines, four others are in the pipeline.

Also Read :- Maha's Virar hospital fire; PM Modi announces Ex-gratia, CM announces probe

The health ministry on Monday also reported that number of people who have tested positive for the new UK variant of SARS-CoV-2 in the country has climbed to 96. However, till Saturday, 90 people were reported to have contracted this new variant. “The total number of persons found infected with the mutant UK strain of COVID-19 is 96,” the ministry had said.

Meanwhile, on January 10 India had recorded the lowest single-day case spike since June 23, 2020 after it reported 16,311 new Covid cases in the last 24 hours. Meanwhile, the virus testing on Sunday was also the lowest with 6.59 lakh samples being tested since the third week of August. As India claims 96.42% recovery rate, the active cases further dropped to 2.2 lakh. With 161 deaths this Sunday, India reported less than 200 fatalities for the first time since the end of May.

To fight off deadly Corona Virus, the Government of India on Monday placed a purchase order with Serum Institute of India (SII) for 11 million doses of Oxford Covid-19 vaccine, Covishield, each costing Rs 210, including the GST, as per official sources. According to the order, each dose of the vaccine has been priced at Rs 200 and with GST of Rs 10 it would cost Rs 210.

The sources further stated that the dispatch of the vaccine is likely to start by late Monday evening.

Also Read :- "25 sickest patients have died": Delhi's Ganga Ram hospital's oxygen SOS
Further reading:
For the latest news and reviews, follow us on Facebook and Twitter ...